Masayoshi Kamon, Shuji Wakatsuki, Masayuki Nakamori, Masanori P Takahashi, Madoka Mori-Yoshimura, Hirofumi Komaki, Toshiyuki Araki. Identification of ZNF850 as a novel CTG repeat expansion-related gene in myotonic dystrophy type 1 patient-derived iPSCs. Human Molecular Genetics. 2025
Nanami Yamanaka, Yukio Takeshita, Ryota Sato, Takashi Nawata, Tatsuya Okafuji, Susumu Fujikawa, Miwako Fujisawa, Kinya Matsuo, Joe Nemoto, Yuki Mizumoto, et al. Acute therapeutic effects and pathophysiology of eosinophilic granulomatosis with polyangiitis neuropathy. BMJ Neurology Open. 2025. 7. 1. e000938-e000938
FUMITAKA SHIMIZU, Nakamori M. Blood-Brain Barrier Disruption in Neuroimmunological Disease. International journal of molecular sciences. 2024
Hicks SM, Frias JA, Mishra SK, Scotti M, Muscato DR, Valero MC, Adams LM, Cleary JD, Nakamori M, Wang E, et al. Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1. Molecular therapy. Nucleic acids. 2024
Kenya Kubo, Yoshinori Oie, Ryota Koto, Nozomi Nishida, Chifune Kai, Sayo Maeno, Tomoya Kubota, Masayuki Nakamori, Masanori P Takahashi, Motokazu Tsujikawa, et al. Analysis of Corneal Phenotypes in Japanese Patients With Myotonic Dystrophy Type 1. Cornea. 2024
T. Uehara, C. J. Choong, H. Hayakawa, Y. Kasahara, T. Nagata, T. Yokota, K. Baba, M. Nakamori, S. Obika, H. Mochizuki. Antisense Oligonucleotides Containing Amido-Bridged Nucleic Acid Downregulate SNCA Expression and Improve Motor Function in Parkinson's disease Mouse Models. MOVEMENT DISORDERS. 2017. 32